Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Wockhardt Founder Seeks GST Exemption on India-Discovered Antibiotics to Enhance Affordability

Farhat Nasim22 Nov 2024 1:19 PM IST

At an event celebrating India's first indigenously developed antibiotic, Nafithromycin, Khorakiwala highlighted the disparity in GST.

Jazz Pharma's Ziihera Gets USFDA Nod To Treat HER2-Positive Biliary Tract Cancer

Farhat Nasim22 Nov 2024 12:30 PM IST

The drug zanidatamab-hrii, sold under the brand name Ziihera, is approved for use in previously treated adults with metastatic HER2-positive biliary...

Cipla Appoints New SMPs as Umang Vohra Steps Down

Setback to Cipla: DoP rejects plea challenging NPPA order for Acivir Tablets pricing

Farhat Nasim21 Nov 2024 6:16 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has rejected Cipla Ltd's review application challenging the ceiling price fixed for Acivir 800 mg...

Pfizer's HYMPAVZI gets European Commission Approval to Treat Severe Hemophilia A and B

Farhat Nasim21 Nov 2024 3:26 PM IST

Delhi: Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for Hympavzi (marstacimab) for the routine...

Strides Pharma Gets USFDA EIR for New York Plant, Inspection Closed With VAI

Strides Pharma Secures NCLT Approval for OneSource, India's First Specialty Pharma CDMO

Farhat Nasim21 Nov 2024 1:56 PM IST

Mumbai: Strides Pharma Science Limited, on Tuesday, announced that the National Company Law Tribunal (NCLT), Mumbai Bench, has approved its Scheme of...

Sun Pharma unit Taro recalls over 17k units of antifungal medication in US

Cipla Recalls Lanthanum Carbonate Tablets in US

Farhat Nasim21 Nov 2024 1:38 PM IST

As per the USFDA, New Jersey based Cipla USA, Inc is recalling the affected lot due to "complaints received of crushed and broken tablets".

Fire Destroys Primary Health Centre in Nidmanoor

Hyderabad Pharma Plant Explosion Leaves 1 Dead, 3 Injured

Farhat Nasim21 Nov 2024 1:24 PM IST

Hyderabad: In an unfortunate incident, a chemical reactor explosion at Aurore Pharmaceuticals Private Ltd in Hyderabad claimed life of a worker, while...

Prior Intimation System Under NDCT Rules Wont Apply to Hormones, Cytotoxics, Beta-Lactams, Certain Biologics: CDSCO

Sage Therapeutics' Experimental Drug for Huntington's Disease Fails Mid-Stage Trial

Farhat Nasim21 Nov 2024 11:30 AM IST

The drug, dalzanemdor, did not significantly improve cognitive function in patients compared to placebo after 84 days, failing to meet the main goal

Drug Prices Set to Rise as NPPA Clears WPI-Linked Hike for 2025

NPPA Revises Ceiling Prices for 6 Drugs Including Clarithromycin, Vitamin C, Details

Farhat Nasim20 Nov 2024 4:08 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced revised ceiling prices for six drug formulations following review orders...

Lupin Gets USFDA Tentative Approval for Generic Anesthesia Reversal Drug Sugammadex

Lupin's generic drug to treat ADHD symptoms gets USFDA approval

Farhat Nasim20 Nov 2024 2:57 PM IST

Mumbai: Lupin Limited announced on Tuesday that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its...

Mercks Enlicitide Outperforms Rivals in Cutting Bad Cholesterol in Late-Stage Trial

Merck's Injectable Keytruda Proves Effective in Trial, Promises Easier Cancer Treatment

Farhat Nasim20 Nov 2024 2:01 PM IST

Merck was testing the injectable version of the world's biggest selling drug in a late stage trial of patients with a type of lung cancer.

Aurobindo Pharma arm Unit IV gets 5 USFDA observations

USFDA Inspection: Dr Reddy's gets Form 483 with 7 observations for Bollaram facility

Farhat Nasim20 Nov 2024 1:48 PM IST

New Delhi: Dr Reddy's Laboratories Ltd on Tuesday said the US health regulator has issued a Form 483 with seven observations to its active...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok